Article Versions Notes

Al Rihani SB, Smith MK, Bikmetov R, Deodhar M, Dow P, Turgeon J, Michaud V. Risk of Adverse Drug Events Following the Virtual Addition of COVID-19 Repurposed Drugs to Drug Regimens of Frail Older Adults with Polypharmacy. Journal of Clinical Medicine. 2020; 9(8):2591. https://doi.org/10.3390/jcm9082591

Al Rihani, Sweilem B., Matt K. Smith, Ravil Bikmetov, Malavika Deodhar, Pamela Dow, Jacques Turgeon, and Veronique Michaud. 2020. "Risk of Adverse Drug Events Following the Virtual Addition of COVID-19 Repurposed Drugs to Drug Regimens of Frail Older Adults with Polypharmacy" Journal of Clinical Medicine 9, no. 8: 2591. https://doi.org/10.3390/jcm9082591

Al Rihani, S. B., Smith, M. K., Bikmetov, R., Deodhar, M., Dow, P., Turgeon, J., & Michaud, V. (2020). Risk of Adverse Drug Events Following the Virtual Addition of COVID-19 Repurposed Drugs to Drug Regimens of Frail Older Adults with Polypharmacy. Journal of Clinical Medicine, 9(8), 2591. https://doi.org/10.3390/jcm9082591